Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2013 1
2016 1
2017 1
2018 2
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Selective staining and eradication of cancer cells by protein-carrying DARPin-functionalized liposomes.
Deyev S, Proshkina G, Baryshnikova O, Ryabova A, Avishai G, Katrivas L, Giannini C, Levi-Kalisman Y, Kotlyar A. Deyev S, et al. Among authors: proshkina g. Eur J Pharm Biopharm. 2018 Sep;130:296-305. doi: 10.1016/j.ejpb.2018.06.026. Epub 2018 Jun 26. Eur J Pharm Biopharm. 2018. PMID: 29959035 Free article.
Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.
Vorobyeva A, Bragina O, Altai M, Mitran B, Orlova A, Shulga A, Proshkina G, Chernov V, Tolmachev V, Deyev S. Vorobyeva A, et al. Among authors: proshkina g. Contrast Media Mol Imaging. 2018 Jun 6;2018:6930425. doi: 10.1155/2018/6930425. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 29977173 Free PMC article.
Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties.
Deyev S, Vorobyeva A, Schulga A, Proshkina G, Güler R, Löfblom J, Mitran B, Garousi J, Altai M, Buijs J, Chernov V, Orlova A, Tolmachev V. Deyev S, et al. Among authors: proshkina g. Mol Pharm. 2019 Mar 4;16(3):995-1008. doi: 10.1021/acs.molpharmaceut.8b00922. Epub 2019 Feb 8. Mol Pharm. 2019. PMID: 30608701
DARPin_9-29-Targeted Mini Gold Nanorods Specifically Eliminate HER2-Overexpressing Cancer Cells.
Proshkina G, Deyev S, Ryabova A, Tavanti F, Menziani MC, Cohen R, Katrivas L, Kotlyar A. Proshkina G, et al. ACS Appl Mater Interfaces. 2019 Sep 25;11(38):34645-34651. doi: 10.1021/acsami.9b10441. Epub 2019 Sep 10. ACS Appl Mater Interfaces. 2019. PMID: 31448887
Synthesis, Characterization, and Selective Delivery of DARPin-Gold Nanoparticle Conjugates to Cancer Cells.
Deyev S, Proshkina G, Ryabova A, Tavanti F, Menziani MC, Eidelshtein G, Avishai G, Kotlyar A. Deyev S, et al. Among authors: proshkina g. Bioconjug Chem. 2017 Oct 18;28(10):2569-2574. doi: 10.1021/acs.bioconjchem.7b00410. Epub 2017 Aug 22. Bioconjug Chem. 2017. PMID: 28806065
Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.
Sokolova E, Proshkina G, Kutova O, Shilova O, Ryabova A, Schulga A, Stremovskiy O, Zdobnova T, Balalaeva I, Deyev S. Sokolova E, et al. Among authors: proshkina g. J Control Release. 2016 Jul 10;233:48-56. doi: 10.1016/j.jconrel.2016.05.020. Epub 2016 May 10. J Control Release. 2016. PMID: 27178808
Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro.
Mironova KE, Proshkina GM, Ryabova AV, Stremovskiy OA, Lukyanov SA, Petrov RV, Deyev SM. Mironova KE, et al. Among authors: proshkina gm. Theranostics. 2013 Oct 12;3(11):831-40. doi: 10.7150/thno.6715. eCollection 2013. Theranostics. 2013. PMID: 24312153 Free PMC article.
Ancient origin, functional conservation and fast evolution of DNA-dependent RNA polymerase III.
Proshkina GM, Shematorova EK, Proshkin SA, Zaros C, Thuriaux P, Shpakovski GV. Proshkina GM, et al. Nucleic Acids Res. 2006 Jul 28;34(13):3615-24. doi: 10.1093/nar/gkl421. Print 2006. Nucleic Acids Res. 2006. PMID: 16877568 Free PMC article.
Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape.
Shramova E, Proshkina G, Shipunova V, Ryabova A, Kamyshinsky R, Konevega A, Schulga A, Konovalova E, Telegin G, Deyev S. Shramova E, et al. Among authors: proshkina g. Cancers (Basel). 2020 Oct 16;12(10):3014. doi: 10.3390/cancers12103014. Cancers (Basel). 2020. PMID: 33081407 Free PMC article.
Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment.
Shipunova VO, Komedchikova EN, Kotelnikova PA, Zelepukin IV, Schulga AA, Proshkina GM, Shramova EI, Kutscher HL, Telegin GB, Kabashin AV, Prasad PN, Deyev SM. Shipunova VO, et al. Among authors: proshkina gm. ACS Nano. 2020 Oct 27;14(10):12781-12795. doi: 10.1021/acsnano.0c03421. Epub 2020 Sep 16. ACS Nano. 2020. PMID: 32935975
Feedback